Bacterial two-component signalling as a therapeutic target in drug design: Inhibition of NRII by the diphenolic methanes (bisphenols)

Domagala, J. M., Alessi, D., Cummings, M., Gracheck, S., Huang, L., Huband, M., … Wold, S. (1998). Bacterial two-component signalling as a therapeutic target in drug design: Inhibition of NRII by the diphenolic methanes (bisphenols). Advances in Experimental Medicine and Biology. Kluwer Academic/Plenum Publishers. https://doi.org/10.1007/978-1-4615-4897-3_14